Amplifying this point, 5 out of 6 BRCA2 carriers identified by this unselected approach did not meet any guideline and there is ample evidence of reduction in cancer-specific and all-cause mortality by standard of care gene-specific clinical management [8, 40, 41]. Here, BRCA2 is linked to cancer.